Clinical Trials Browser

OTHER × Has results × Xerostomia × Clear all

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia

NCT03552965 2025-09-02

Margin-Based Vs. Robust Photon Radiotherapy Planning in IMRT of HN-SQCC

Phase NA Completed

23 enrolled 21 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Xerostomia

NCT04608773 2024-02-01

Blinded Dry Mouth Spray Crossover Study

Phase NA Completed

129 enrolled 12 charts

Head & Neck

Head and Neck Neoplasms, Xerostomia

NCT02513238 2022-12-28

MESRIX

Phase 2 Completed

30 enrolled 5 charts

Xerostomia

NCT00352118 2017-12-28

Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Phase 2 Terminated

4 enrolled 4 charts

Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Xerostomia, Mucositis

NCT00503776 2017-06-20

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Phase 2 Terminated

41 enrolled 12 charts

Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Deglutition Disorders, Head and Neck Neoplasms, Radiation Injuries, Salivary Gland Neoplasms, Xerostomia, Mucositis

NCT01682031 2014-08-22

Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy

Phase 2 Terminated

18 enrolled 8 charts

Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Radiation Injuries, Xerostomia, Mucositis

Clinical Trials

ACUPUNCTURE

Margin-Based Vs. Robust Photon Radiotherapy Planning in IMRT of HN-SQCC

Blinded Dry Mouth Spray Crossover Study

MESRIX

Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy